- Home
- CLRB vs NCPL Comparison
CLRB vs NCPL Comparison
Compare CLRB & NCPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLRB
- NCPL
- Stock Information
- Founded
- CLRB 2002
- NCPL 1984
- Country
- CLRB United States
- NCPL United States
- Employees
- CLRB N/A
- NCPL N/A
- Industry
- CLRB Biotechnology: Pharmaceutical Preparations
- NCPL Investment Managers
- Sector
- CLRB Health Care
- NCPL Finance
- Exchange
- CLRB Nasdaq
- NCPL Nasdaq
- Market Cap
- CLRB 17.6M
- NCPL 19.3M
- IPO Year
- CLRB N/A
- NCPL N/A
- Fundamental
- Price
- CLRB $4.92
- NCPL $3.33
- Analyst Decision
- CLRB Hold
- NCPL
- Analyst Count
- CLRB 2
- NCPL 0
- Target Price
- CLRB N/A
- NCPL N/A
- AVG Volume (30 Days)
- CLRB 173.9K
- NCPL 1.1M
- Earning Date
- CLRB 08-12-2025
- NCPL 09-15-2025
- Dividend Yield
- CLRB N/A
- NCPL N/A
- EPS Growth
- CLRB N/A
- NCPL N/A
- EPS
- CLRB N/A
- NCPL N/A
- Revenue
- CLRB N/A
- NCPL $812,612.00
- Revenue This Year
- CLRB N/A
- NCPL N/A
- Revenue Next Year
- CLRB N/A
- NCPL $101.16
- P/E Ratio
- CLRB N/A
- NCPL N/A
- Revenue Growth
- CLRB N/A
- NCPL N/A
- 52 Week Low
- CLRB $4.36
- NCPL $1.41
- 52 Week High
- CLRB $94.50
- NCPL $11.90
- Technical
- Relative Strength Index (RSI)
- CLRB 36.75
- NCPL 38.02
- Support Level
- CLRB $4.74
- NCPL $2.85
- Resistance Level
- CLRB $5.33
- NCPL $5.14
- Average True Range (ATR)
- CLRB 0.40
- NCPL 1.30
- MACD
- CLRB -0.00
- NCPL -0.57
- Stochastic Oscillator
- CLRB 18.43
- NCPL 2.80
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.
About NCPL Netcapital Inc.
Netcapital Inc is a financial technology company. The company facilitates the growth of private companies by providing fundraising services and other consulting services. The company's online private investment platform connects entrepreneurs and investors, enabling companies to raise capital digitally. The Company operates in a single operating segment, which is the provision of fintech services.